Search Results 111-120 of 20668 for colitis
... colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis.
The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active ...
Microscopic colitis is an inflammatory condition in which there's an abnormal immune response in the lining of the colon. This leads to watery stools. The ...
This results in a bile buildup that can cause inflammation. Other causes of cholecystitis include bile duct changes, tumors, serious illness and certain ...
... colitis or Crohn's disease. This new vaccine has been found to be more effective than the existing vaccine Engerix in people without ulcerative colitis or ...
Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to ulcerative colitis or Crohn's disease focuses on reducing inflammation in the ...
This common colon disease develops when small pouches form in the colon wall and become inflamed, causing pain, fever and abnormal stool function.
Budesonide is a steroid (cortisone-like) medicine. Budesonide extended-release tablets are used to help get active mild to moderate ulcerative colitis under ...
For treatment of ulcerative colitis: For oral dosage form (enteric-coated tablets):. Adults—At first, 500 to 1000 milligrams (mg) every 6 to 8 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.